Black Diamond Therapeutics, Inc. (BDTX) vs Vivani Medical, Inc. (VANI)

A side-by-side comparison of Black Diamond Therapeutics, Inc. and Vivani Medical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BDTX vs VANI

growth of $100 · dividends reinvested · last 7y
BDTX -95.1% (-35.0%/yr)VANI -91.9% (-30.2%/yr)VANI compounded faster over this window
0100200300Start $100202120222023202420252026$5$8
BDTX VANI

BDTX vs VANI: by the numbers

  • •VANI is the larger company ($107M vs $103M market cap).
  • •BDTX is profitable (31.95% net margin) while VANI runs a net loss (0.00%).

Metrics side by side

Valuation

MetricBDTXVANI
P/B ratio1.075.64

Profitability

MetricBDTXVANI
Gross margin99.54%0.00%
Operating margin28.39%0.00%
Net margin31.95%0.00%
ROE-44.29%-138.73%
ROIC-47.54%-73.94%

Growth (annualized)

MetricBDTXVANI
Total return CAGR (5Y)-24.47%-32.72%

Frequently asked

Is BDTX or VANI more profitable?
BDTX runs the higher net margin — BDTX at 31.95% versus VANI at 0.00%.
How have BDTX and VANI total returns compared?
Over the past 5 years, BDTX delivered -24.47% and VANI delivered -32.72% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.